top of page
DSCF1775_stent2.jpg
DSCF1775_stent2_edited.jpg

Expanding treatment options for lower limb ischaemia with Diamond-F self-expanding drug-eluting stent

Global Vascular Co., Ltd. is a developer of a drug-eluting stent delivery system for lower limb artery disease, which achieves the world's first cutting-edge endovascular treatment using nanotechnology.

Our Vision

Towards a future where the simple act of walking is a given, we strive.

News

Key Technology

The stent surface is equipped with BIOZONE Coating® technology, a nanotechnology that suppresses thrombus adhesion. By further suppressing the release of harmful nickel ions in the body, this technology allows for endothelialization, the process by which cells integrate with the stent, without inhibiting it, enabling a stent treatment that is gentle on the body.

Our Partners

ロゴ-08.png
ロゴ2-10.png
ロゴ2-05.png
ロゴ-13.png
yamashina.png
Logo-03.png
AMED_EN.png
img_logo_header.png

Company Profile

Company Name

Global Vascular Co., Ltd.

Representative

Keneta BITO, Shunto MAEGAWA

Founded

12/12/2022

Capital

282,000,000JPY

Location

Ichigaya Science and Technology Innovation Center Building 2F, 3-8 Ichigayatamachi, Shinjuku-ku, Tokyo, JAPAN 162-0843

Location

THE GATE ICHIGAYA  4F, 3-6 Ichigayatamachi, Shinjuku-ku, Tokyo, JAPAN 162-0843

Business description

Design and development of medical equipment, research, consulting, etc.

Investor

Diamond Medino Capital Inc.

bottom of page